Integrative Proteogenomic Analyses Identify TOPs as Prognostic Markers and Therapeutic Targets in Sarcoma
Genchun Wang,Kai Sun,Li Ting Liu,Jiamin Lin,Xudong Yao,Jiachao Guo,Zhou Guo,Liang Cai Hou,Ting Xu,fengjing guo
DOI: https://doi.org/10.21203/rs.3.rs-139866/v1
2021-01-01
Abstract:Abstract Background: Soft-tissue sarcomas (STSs) are uncommon malignant tumors with varied highly aggressive and histological presentations. They comprise approximately 1% of newly diagnosed adult malignancies each year, but the sarcoma's accurate diagnosis prediction remains a challenge. TOP1/1MT/2A/2B/3A/3B were aberrantly expressed in tumors and associated with tumor progression, but the roles of the six TOP members in sarcoma in clinical trials remains uncertain.Method: Relationship between the mRNA levels of the TOPs and the clinicopathological parameters evaluated by Oncomine, GEPIA, cBioPortal, TIMER, Metascape, TCGAportal, Kaplan-Meier plotter, String, and Linkedomics. We focused on the potential mechanism of TOPs in the occurrence and development of SARC. We were investigating the prognostic value of TOPs expression in patients with SARC and correlations with clinicopathological features.Results: In patients with SARC, TOPs mRNA expression level upregulated. Increased TOP family members' expression was associated with different subtypes, FNCLCC grades, Local recurrence, DNA methylation, different miRNA clusters, and poor prognosis in SARC patients. We further found that TOPs showed distinct immune infiltration patterns, TOP gene mutation rate and that TOP somatic copy number variations were negatively related to the survival of sarcoma patients. Survival data analyzed that high transcription levels of TOPs were associated with low overall survival and disease-free survival in sarcoma. Enrichment analyses for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genome (KEGG) were conducted to reveal TOPs enriched in DNA topological change, Chromosome segregation, DNA, replication signaling pathway. BUB1B, CENPF, SPC25, NUF2, KNL1SGO1, RPS20, SNRPD3, and MED9 were significantly associated with TOP mutations. These Hub gene expressions in SARC were increased and were associated with unfavorable prognosis.Conclusion: The results show that multiple TOP family members are involved in the development and progression of sarcoma and suggest that TOPs can be used as potential targets for the diagnosis and treatment of sarcoma. TOP1/1MT/2A/2B/3A/3B may affect the prognosis of SARC through DNA topological change, Chromosome segregation, DNA, replication signaling pathway.